With more and more states allowing for either medicinal and recreational marijuana sales, many fleets are beginning to show concern about whether or not they need to keep a closer eye on their drivers. No matter the controlled or uncontrolled substance a person imbibes, the effects on their driving ability and the safety of those around them on the highway is a cause for concern that needs to be addressed.
Dr. Denise Valenti, IMMAD LLC, will review driving and marijuana use in general and further discuss the associated dysfunctions to visual and neural pathways at the Fleet Safety Conference in Las Vegas on Wednesday, October 31, 2018. She will also provide additional information regarding the status of roadside testing related to marijuana impairment.
“Marijuana affects self-awareness. A driver cannot accurately self-assess so they do not judge their impairment properly,” says Dr. Valenti. “I compare this to the permanent dysfunctions with Alzheimer’s disease.”
According to the Washington Traffic Safety Commission, drivers testing positive for marijuana - active THC alone-indicative of use within four hours - in fatal crashes are more likely to have killed someone other than themselves at a higher rate than for alcohol positive drivers. The data provided related to the total number of drivers involved for alcohol alone and for THC alone and the number of deaths to pedestrians, bicyclists, other drivers and passengers factor to be such that those drivers positive for active THC alone are six times more likely to have killed someone other than themselves compared to alcohol positive alone. Marijuana drivers in a fatal crash survive the crash at a higher rate than those in alcohol related crashes and thus can refuse to provide blood sampling delaying the test for hours. By then the active THC has dissipated from blood. When taking this into consideration the harm rate to innocent by those positive for marijuana alone, but of all forms, is eight times greater than alcohol The data were reported in the agency’s 2015 report “Driver Toxicology Testing and the Involvement of Marijuana in Fatal Crashes, 2010-2014.”
But how can we test drivers on the roadside? According to Valenti, there is a new possible test on the horizon.
“We have a National Institutes of Health National Institute of Drugs and Addiction Small Business Innovation Research contract to research a simple goggle virtual reality system coupled with a cell phone and blue tooth response button to measure retinal dysfunction,” explains Valenti. “We are finding mid peripheral vision impairments. This is essentially the ‘tunneling’ of vision often reported by marijuana users. The final version will be a quick, simple, objective, sensitive, specific test of marijuana driving impairment for law enforcement. This test will be threshold related and have a number value compared to a large normative data base. That test will take two minutes per eye.”
For more information on this session, visit the Fleet Safety Conference website.
